Objetivo. Determinar las características y la tendencia de los artículos publicados sobre cardiología y medicina cardiovascular en el contexto peruano, y comprender cómo ha cambiado a lo largo de los años. Materiales y métodos. Se realizó un estudio bibliométrico de artículos originales publicados hasta el año 2020 por autores peruanos en revistas indexadas bajo la categoría «Cardiac & Cardiovascular Systems» en Web of Science (WOS). Se incluyeron los artículos según los criterios de selección en el aplicativo web Rayyan y se realizó el análisis bibliométrico mediante el paquete Bibliometrix en el lenguaje de programación R y VOSviewer. Resultados. Se incluyeron 159 artículos publicados, y se observó un incremento del número de publicaciones desde 2015. El artículo más citado fue un ensayo clínico realizado por Fitchett et al. y publicado en 2016. Miranda JJ fue el autor peruano con mayor número artículos publicados seguido de Hernández AV y Málaga G. La filiación institucional con mayor número de artículos originales fue la Universidad Peruana Cayetano Heredia. En cuanto a los términos o palabras clave, se encontró que la mayor cantidad de estudios publicados contaban con términos relacionados con la epidemiología, mientras que en los artículos más recientes, los términos se relacionaron con desenlaces o intervenciones específicas que son utilizados en estudios clínicos. Conclusiones. Se encontró un incremento en los últimos cinco años en la producción científica sobre cardiología y medicina cardiovascular de autores con filiación institucional peruana, con una mayor producción de la Universidad Peruana Cayetano Heredia. La revista con mayores publicaciones de autores con filiación institucional peruana sobre cardiología y medicina cardiovascular fue Circulation, donde también se encontraron dos de los artículos con filiación institucional peruana más citados.
To assess the association between women’s autonomy and intimate partner violence (IPV) against women of childbearing age. Secondary analysis of the 2019 Demographic and Family Health Survey (ENDES / acronym in Spanish) was carried out. The study population was women aged 15–49 years who are currently married or living with a partner. A Poisson family generalized linear regression model was estimated to calculate adjusted prevalence ratios (aPR) for the association between women’s autonomy and IPV with their respective 95% confidence intervals (CI). Data from 18,621 women were analyzed. The highest proportion of women had low autonomy (low: 42%; moderate: 39.2%; high: 18.8%). A prevalence of IPV of 40.1% was found (psychological/verbal: 38.8%; physical: 8.8%; sexual: 2.3%). The adjusted model found that women with a low level of autonomy (aPR: 1.15, 95%CI: 1.01–1.31) had a higher prevalence of IPV compared to women with high autonomy. This association was also found for the specific case of psychological/verbal violence (aPR: 1.15, 95%CI: 1.01–1.31). No association was found between women’s level of autonomy and physical or sexual violence by a partner. Four out of 10 women of childbearing age have experienced IPV in the last 12 months. In general, women with lower levels of autonomy are more likely to present IPV compared to women with high autonomy.
IntroductionST-segment elevation myocardial infarction (STEMI) is the most severe clinical form of acute myocardial infarction, for which the current treatment consists of effective and timely myocardial reperfusion (within 12 hours of symptom onset). However, between 10% and 15% of patients with STEMI arrive at hospital facilities 12 hours after the onset of symptoms (late presentation). Therefore, the objective of the present study will be to determine if late revascularisation (12–72 hours after the onset of symptoms) affects the indicators of cardiovascular mortality, reinfarction, recurrent infarction, hospitalisation for heart failure and post infarction angina compared with no late revascularisation in patients with STEMI.Methods and analysisA systematic literature search of PubMed, The Cochrane Library, Embase, Cumulative Index to Nursing and Allied Health Literature (CINAHL), Web of Science, Scopus and Global Health will be conducted. Publications in English, Portuguese or Spanish that report the clinical results of primary percutaneous revascularisation (primary PCI) in adult patients with STEMI 12–72 hours after the onset of symptoms will be included. Studies with participants with a diagnosis other than STEMI or patients with STEMI of >12 hours complicated by heart failure, cardiogenic shock or ventricular arrhythmias, and studies of combined interventions (pharmacoinvasive strategy) were excluded. Two independent authors will identify the relevant publications, and discrepancies will be adjudicated by a third author. Data extraction will be performed by two independent authors and verified by a third author. Risk of bias of studies will be assessed using the Cochrane ‘risk of bias’ tool (RoB 2) or Risk Of Bias In Non-randomised Studies - of Interventions (ROBINS-I) tool. If appropriate, a meta-analysis will be performed in order to examine the effect of late revascularisation in clinical outcomes of interest.Ethics and discussionThis study will use published data only, thus, ethical approval will not be required. The results will be disseminated through peer-reviewed publication and conference presentations.PROSPERO registration numberCRD42021283429.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.